92 related articles for article (PubMed ID: 11963347)
1. [Cannabis-related flash-back, a medico-legal case].
Niveau G
Encephale; 2002; 28(1):77-9. PubMed ID: 11963347
[TBL] [Abstract][Full Text] [Related]
2. [Flashback following use of cannabis--a review].
Fischer J; Täschner KL
Fortschr Neurol Psychiatr; 1991 Nov; 59(11):437-46. PubMed ID: 1761271
[TBL] [Abstract][Full Text] [Related]
3. Driving under the influence of cannabis: a 10-year study of age and gender differences in the concentrations of tetrahydrocannabinol in blood.
Jones AW; Holmgren A; Kugelberg FC
Addiction; 2008 Mar; 103(3):452-61. PubMed ID: 18190663
[TBL] [Abstract][Full Text] [Related]
4. Concentration-effect relationship of delta-9-tetrahydrocannabiol and prediction of psychotropic effects after smoking marijuana.
Harder S; Rietbrock S
Int J Clin Pharmacol Ther; 1997 Apr; 35(4):155-9. PubMed ID: 9112136
[TBL] [Abstract][Full Text] [Related]
5. [Delta-9-tetrahydrocannabinol pharmacokinetics].
Goullé JP; Saussereau E; Lacroix C
Ann Pharm Fr; 2008 Aug; 66(4):232-44. PubMed ID: 18847571
[TBL] [Abstract][Full Text] [Related]
6. [Serum cannabinoid levels 24 to 48 hours after cannabis smoking].
Skopp G; Richter B; Pötsch L
Arch Kriminol; 2003; 212(3-4):83-95. PubMed ID: 14639811
[TBL] [Abstract][Full Text] [Related]
7. Criminal responsibility and cannabis use: psychiatric review and proposed guidelines.
Niveau G
J Forensic Sci; 2002 May; 47(3):451-8. PubMed ID: 12051322
[TBL] [Abstract][Full Text] [Related]
8. Cognition and motor control as a function of Delta9-THC concentration in serum and oral fluid: limits of impairment.
Ramaekers JG; Moeller MR; van Ruitenbeek P; Theunissen EL; Schneider E; Kauert G
Drug Alcohol Depend; 2006 Nov; 85(2):114-22. PubMed ID: 16723194
[TBL] [Abstract][Full Text] [Related]
9. Persisting visual hallucinations and illusions in previously drug-addicted patients.
Gaillard MC; Borruat FX
Klin Monbl Augenheilkd; 2003 Mar; 220(3):176-8. PubMed ID: 12664374
[TBL] [Abstract][Full Text] [Related]
10. Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users.
Curran HV; Brignell C; Fletcher S; Middleton P; Henry J
Psychopharmacology (Berl); 2002 Oct; 164(1):61-70. PubMed ID: 12373420
[TBL] [Abstract][Full Text] [Related]
11. Exposure to marijuana smoke impairs memory retrieval in mice.
Niyuhire F; Varvel SA; Martin BR; Lichtman AH
J Pharmacol Exp Ther; 2007 Sep; 322(3):1067-75. PubMed ID: 17586723
[TBL] [Abstract][Full Text] [Related]
12. [Cannabis affects driving skills].
Khiabani HZ; Christophersen AS; Mørland J
Tidsskr Nor Laegeforen; 2007 Mar; 127(5):583-4. PubMed ID: 17332811
[TBL] [Abstract][Full Text] [Related]
13. [Variability of cannabinoid findings in blood].
Skopp G; Schmitt G
Arch Kriminol; 2011; 228(1-2):46-59. PubMed ID: 21850885
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Cozart DDSV test for cannabis in oral fluid.
Kintz P; Brunet B; Muller JF; Serra W; Villain M; Cirimele V; Mura P
Ther Drug Monit; 2009 Feb; 31(1):131-4. PubMed ID: 19155965
[TBL] [Abstract][Full Text] [Related]
15. [Cannabis and myocardial infarction without angiographic stenosis in young patient: guilty or not guilty? A case report].
Leblanc A; Tirel-Badets A; Paleiron N; Castellant P; Cornily JC; Andre M; Grassin F; Feuvrier Y; Blanchard C; Zagnoli F; Quiniou G; Vinsonneau U
Ann Cardiol Angeiol (Paris); 2011 Jun; 60(3):154-8. PubMed ID: 21306702
[TBL] [Abstract][Full Text] [Related]
16. Adverse effects of cannabis on health: an update of the literature since 1996.
Kalant H
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Aug; 28(5):849-63. PubMed ID: 15363608
[TBL] [Abstract][Full Text] [Related]
17. Frequency and irregularity of heart rate in drivers suspected of driving under the influence of cannabis.
Khiabani HZ; Mørland J; Bramness JG
Eur J Intern Med; 2008 Dec; 19(8):608-12. PubMed ID: 19046727
[TBL] [Abstract][Full Text] [Related]
18. Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users.
Ramaekers JG; Kauert G; Theunissen EL; Toennes SW; Moeller MR
J Psychopharmacol; 2009 May; 23(3):266-77. PubMed ID: 18719045
[TBL] [Abstract][Full Text] [Related]
19. Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms.
Budney AJ; Vandrey RG; Hughes JR; Moore BA; Bahrenburg B
Drug Alcohol Depend; 2007 Jan; 86(1):22-9. PubMed ID: 16769180
[TBL] [Abstract][Full Text] [Related]
20. Tetrahydrocannabinols in clinical and forensic toxicology.
Kochanowski M; Kała M
Przegl Lek; 2005; 62(6):576-80. PubMed ID: 16225128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
